AI Science Tracker
EN

Using machine learning algorithms to predict MACE in peritoneal dialysis patients.

Second Affiliated Hospital of Xiamen Medical College; Fujian Provincial Hospital, Fujian Medical University · 30 Mar 2026 · medicine

Discovery

Using machine learning algorithms to predict MACE in peritoneal dialysis patients.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning models predicted major adverse cardiac events in a retrospective peritoneal-dialysis cohort and a separate hospital cohort. The study reports development AUCs of 0.80 overall, 0.86 at one year, and 0.75 at five years, with external-cohort AUC 0.768; its broad composite outcome and retrospective design do not establish intervention benefit.

Technology: XGBoost, random forest, and AdaBoost rank baseline clinical variables and predict overall, one-year, and five-year MACE risk.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning models estimate MACE risk from baseline clinical factors.
Test and result
Among 1,006 patients, 606 formed the development cohort and 400 an external hospital cohort; reported external-validation AUC was 0.768.
Limitation / still unknown
Retrospective data and a composite including cardiovascular hospitalization and all-cause mortality; prospective implementation and patient benefit were not tested.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13039696/ · https://www.nature.com/articles/s41598-026-45362-y

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary source full-text Methods and Results; version date and reported validation scope checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.